Market Value781,397,000
Total Holdings46
File Date2020-11-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RETA / Reata Pharmaceuticals Inc - Class A
FULC / Fulcrum Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
CHAQ.U / Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of , and one
APTO / Aptose Biosciences Inc.
XFOR / X4 Pharmaceuticals, Inc.
US74257L1089 / Principia Biopharma Inc.
GBIO / Generation Bio Co.
FUSN / Fusion Pharmaceuticals Inc.
ETNB / 89bio, Inc.
APLT / Applied Therapeutics, Inc.
AFIB / Acutus Medical, Inc.
NARI / Inari Medical, Inc.
AKUS / Akouos Inc
ARYBU / ARYA Sciences Acquisition Corp II
NUVB / Nuvation Bio Inc.
/ Therapeutics Acquisition Corp. Class A
ZGNX / Zogenix Inc
OBSV / ObsEva SA.
RLAY / Relay Therapeutics, Inc.
GMTX / Gemini Therapeutics Inc
NKTX / Nkarta, Inc.
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
ITOS / iTeos Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
AMTI / Applied Molecular Transport Inc.
KALV / KalVista Pharmaceuticals, Inc.
INBX / Inhibrx Biosciences, Inc.
BDTX / Black Diamond Therapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
VINC / Vincerx Pharma, Inc.
KROS / Keros Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock)
FMTX / Forma Therapeutics Holdings Inc
HRMY / Harmony Biosciences Holdings, Inc.
IGMS / IGM Biosciences, Inc.
OM / Outset Medical, Inc.
PCVX / Vaxcyte, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
PASG / Passage Bio, Inc.
/ Pandion Therapeutics Inc
ATHA / Athira Pharma, Inc.
LUMO / Lumos Pharma, Inc.
TNGX / Tango Therapeutics, Inc.
BLU / Bellus Health Inc
STRO / Sutro Biopharma, Inc.
PMVP / PMV Pharmaceuticals, Inc.
ARNA / Arena Pharmaceuticals Inc
RAPT / RAPT Therapeutics, Inc.
AKBA / Akebia Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
GBT / Global Blood Therapeutics Inc.
BTAI / BioXcel Therapeutics, Inc.
ISEE / IVERIC bio Inc
ALXO / ALX Oncology Holdings Inc.
COGT / Cogent Biosciences, Inc.
CLDX / Celldex Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
CYTK / Cytokinetics, Incorporated
RPTX / Repare Therapeutics Inc.
RNA / Avidity Biosciences, Inc.
LRMR / Larimar Therapeutics, Inc.
ANNX / Annexon, Inc.
SRPT / Sarepta Therapeutics, Inc.